WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a significant growth in short interest in December. As of December 31st, there was short interest totaling 76,332 shares, a growth of 52.4% from the December 15th total of 50,075 shares. Based on an average trading volume of 107,942 shares, the short-interest ratio is presently 0.7 days. Based on an average trading volume of 107,942 shares, the short-interest ratio is presently 0.7 days.

WuXi Biologics (Cayman) Stock Performance

Shares of OTCMKTS:WXXWY opened at $10.02 on Friday. WuXi Biologics has a 12 month low of $4.14 and a 12 month high of $11.21. The company’s fifty day simple moving average is $8.54 and its 200 day simple moving average is $8.60.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.